The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions
dc.creator | Varsamas C., Kalkanis A., Gourgoulianis K.I., Malli F. | en |
dc.date.accessioned | 2023-01-31T10:26:43Z | |
dc.date.available | 2023-01-31T10:26:43Z | |
dc.date.issued | 2020 | |
dc.identifier | 10.1155/2020/1283590 | |
dc.identifier.issn | 11982241 | |
dc.identifier.uri | http://hdl.handle.net/11615/80414 | |
dc.description.abstract | Background. Thoracic ultrasound is an essential tool in the daily clinical care of pleural effusions and especially parapneumonic pleural effusions (PPEs), in terms of diagnosis, management, and follow-up. Hypoechogenicity index (HI) is a quantitative marker of pleural fluid echogenicity. We aimed to examine associations of HI with pleural inflammation in patients with PPE. Methods. All patients included underwent a thoracic ultrasound with HI determination at the first day of their admission for a PPE. Thoracentesis was performed in all patients. Demographics, laboratory measurements, and clinical data were collected prospectively and recorded in all subjects. Results. Twenty-four patients with PPE were included in the study. HI was statistically significantly correlated with intensity of inflammation as suggested by pleural fluid LDH (p<0.001, r = -0.831), pleural fluid glucose (p=0.022, r = 0.474), and pleural fluid pH (p<0.001, r = 0.811). HI was correlated with ADA levels (p=0.005, r = -0.552). We observed a statistically significant correlation of HI with pleural fluid total cell number (p<0.001, r = -0.657) and polymorphonuclears percentage (p=0.02, r = -0.590), as well as days to afebrile (p=0.046, r = -0.411), duration of chest tube placement (p<0.001, r = -0.806), and days of hospitalization (p=0.013, r = -0.501). Discussion. HI presents a fast, easily applicable, objective, and quantitative marker of pleural inflammation that reliably reflects the intensity of pleural inflammation and could potentially guide therapeutic management of PPE. © 2020 Charalampos Varsamas et al. | en |
dc.language.iso | en | en |
dc.source | Canadian Respiratory Journal | en |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85094219966&doi=10.1155%2f2020%2f1283590&partnerID=40&md5=89a16e2a19bdddd1a89a27735e045b6e | |
dc.subject | albumin | en |
dc.subject | glucose | en |
dc.subject | lactate dehydrogenase | en |
dc.subject | glucose | en |
dc.subject | lactate dehydrogenase | en |
dc.subject | adult | en |
dc.subject | aged | en |
dc.subject | antibiotic therapy | en |
dc.subject | Article | en |
dc.subject | biochemical analysis | en |
dc.subject | cell count | en |
dc.subject | clinical article | en |
dc.subject | echogenicity | en |
dc.subject | echography | en |
dc.subject | female | en |
dc.subject | follow up | en |
dc.subject | hospital admission | en |
dc.subject | hospitalization | en |
dc.subject | human | en |
dc.subject | hypoechogenicity index | en |
dc.subject | male | en |
dc.subject | middle aged | en |
dc.subject | parapneumonic pleural effusion | en |
dc.subject | pH measurement | en |
dc.subject | physical parameters | en |
dc.subject | pleura effusion | en |
dc.subject | pleura fluid | en |
dc.subject | pleurisy | en |
dc.subject | polymorphonuclear cell | en |
dc.subject | priority journal | en |
dc.subject | prospective study | en |
dc.subject | septic shock | en |
dc.subject | thoracocentesis | en |
dc.subject | thorax radiography | en |
dc.subject | chest tube | en |
dc.subject | complication | en |
dc.subject | cytology | en |
dc.subject | diagnostic imaging | en |
dc.subject | exudate | en |
dc.subject | inflammation | en |
dc.subject | length of stay | en |
dc.subject | metabolism | en |
dc.subject | neutrophil | en |
dc.subject | pH | en |
dc.subject | pleura effusion | en |
dc.subject | pneumonia | en |
dc.subject | treatment duration | en |
dc.subject | very elderly | en |
dc.subject | Adult | en |
dc.subject | Aged | en |
dc.subject | Aged, 80 and over | en |
dc.subject | Chest Tubes | en |
dc.subject | Duration of Therapy | en |
dc.subject | Exudates and Transudates | en |
dc.subject | Female | en |
dc.subject | Glucose | en |
dc.subject | Humans | en |
dc.subject | Hydrogen-Ion Concentration | en |
dc.subject | Inflammation | en |
dc.subject | L-Lactate Dehydrogenase | en |
dc.subject | Length of Stay | en |
dc.subject | Male | en |
dc.subject | Middle Aged | en |
dc.subject | Neutrophils | en |
dc.subject | Pleural Effusion | en |
dc.subject | Pneumonia | en |
dc.subject | Thoracentesis | en |
dc.subject | Ultrasonography | en |
dc.subject | Hindawi Limited | en |
dc.title | The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions | en |
dc.type | journalArticle | en |
Dateien zu dieser Ressource
Dateien | Größe | Format | Anzeige |
---|---|---|---|
Zu diesem Dokument gibt es keine Dateien. |